Summary
Immunophotonics Inc
Founded in 2012
Description
Immunophotonics has developed an in situ therapeutic cancer vaccine (inCVAX) for the treatment of solid tumor cancers. inCVAX is an in vivo immunotherapy that activates a multitude of the immune systems cells to ultimately induce a systemic antitumor ...
Strengths
- Immunophotonics Inc has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Revenue growth is more steady than the industry average
- Web traffic rankings are better than the industry average
Weaknesses
- Since Immunophotonics Inc was founded, the company has experienced slower revenue growth than the industry average
Annual Revenue
Immunophotonics Inc's annual revenue
$2748000
Based on Kona Equity data
-
Revenue per employee
$211385
-
Variance of revenue growth
0.09
-
Annual revenue growth since founding
$229000
-
Revenue growth rate from first known quarter to current
-35.6%
Employee Count
13 employees
-
Employee growth rate from first known quarter to current
-31.6%
Executives
Troy Jiao
Vice President
t**@immunophotonics.comLu Alleruzzo
CEO
l**@immunophotonics.comAlex Hurst
General Counsel & Director, Operations
a**@immunophotonics.comThomas Hode
Chief Innovation Officer, President, & Co-Founder
t**@immunophotonics.comSiu Kit
Senior Vice President, Science & Research
s**@immunophotonics.comJoseph Raker
Senior VP, CMC
j**@immunophotonics.comAbby Delawder
Principal Chemist
a**@immunophotonics.comDiane Beatty
Vice President, Regulatory & Clinical Affairs
d**@immunophotonics.comG Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G5 Variance of revenue growth is less than the industry average
- G7 Website traffic rankings are better than the industry average
Web Analysis
-
Rank
1.81 M
-
Daily time
3:59
Location
Unlock unlimited leads
Similar Companies
Urodelia
urodelia.com- Founded in 2003
- Location: Labege, Occitania
- Annual Revenue: $5.3M
- Employees: 14
- Urodelia est une socit spcialise dans les phosphates de calcium. Sa recherche se tourne vers le dveloppement de nouveaux traitements anticancreux.
Intezyne Technologies
intezyne.com- Founded in 2004
- Location: Tampa, FL
- Annual Revenue: $6.5M
- Employees: 11
- Intezyne Technologies is a clinical stage biopharmaceutical company developing novel anti-cancer therapies. Its lead products are IT 141, a novel topoisomerase 1 (TOP I) inhibitor, and IT 139, a novel GRP78 inhibitor. Intezyne Technologies develops syn...
Step Pharma
step-ph.com- Founded in 2014
- Location: Archamps, Auvergne-Rhone-Alpes
- Annual Revenue: $2.1M
- Employees: 9
- Step Pharma is a biotech company developing novel innovative therapies to treat cancer and autoimmune diseases. Our lead asset, STP938 is a first in class, highly selective, orally bioavailable, targeted oncology therapy that aims to become a key drug ...
CNS Pharmaceuticals , Inc.
cnspharma.com- Founded in 2017
- Location: Houston, TX
- Annual Revenue: $1.7M
- Employees: 3
- CNS Pharmaceuticals is a biotechnology company specializing in the development of novel treatments for brain tumors. CNS Pharmaceuticals is developing novel treatments for primary and metastatic cancers of the brain and central nervous system. Its lead...
Anokion
anokion.com- Founded in 2006
- Location: Ecublens, Vaud
- Annual Revenue: $10.4M
- Employees: 47
- Anokion is harnessing the power of natural immune equilibrium to develop solutions for antigen-specific immune tolerance.
KuDOS Pharmaceuticals
kudospharma.co.uk- Location: Cambridge, Cambridgeshire
- Annual Revenue: $11.5M
- Employees: 41
- This page is intended as a forum to discuss recruitment considerations and AstraZeneca employment highlights. It is not intended as a forum for discussing AstraZeneca Pharmaceuticals, other companies products, or the reporting of side effects associate...
Key Information
- Name: Immunophotonics Inc
- Category: Pharmaceuticals
- Industry: Biotechnology Company
- SIC: 2834; 283
- NAICS: 541711; 541
See similar companies
-
By City St. Louis Small Biotechnology Company in St. Louis Mid-size Biotechnology Company in St. Louis Pharmaceuticals in St. Louis Small Pharmaceuticals in St. Louis Mid-size Pharmaceuticals in St. Louis
-
By State MO Small companies in MO Pharmaceuticals in MO Small Pharmaceuticals in MO Mid-size Pharmaceuticals in MO Small Biotechnology Company in MO Mid-size Biotechnology Company in MO
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Pharmaceuticals and Biotechnology Company
-
Firmographic data G Score of 6 Founded in 2012 SIC: 2834 SIC: 283 NAICS: 541711 NAICS: 541 #Pharmaceuticals #Healthcare #Drug Manufacturing & Research #Biotechnology
Frequently Asked Questions
Immunophotonics Inc's headquarters are located at 4320 Forest Park Ave. Ste. 303 303 St. Louis, MO 63108.
Immunophotonics Inc's official website is immunophotonics.com
Immunophotonics Inc's annual revenue is $2.7 M.
Immunophotonics Inc's SIC: 2834; 283
Immunophotonics Inc's NAICS: 541711; 541.
Immunophotonics Inc has 13 employees
Immunophotonics Inc is in the industry of Pharmaceuticals.
